131 related articles for article (PubMed ID: 37098385)
1. Antimicrobial effect of quercetin against Streptococcus pneumoniae.
Willian de Alencar Pereira E; Fontes VC; da Fonseca Amorim EA; de Miranda RCM; Carvalho RC; de Sousa EM; Cutrim SCPF; Alves Lima CZGP; de Souza Monteiro A; Neto LGL
Microb Pathog; 2023 Jul; 180():106119. PubMed ID: 37098385
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential activity of quercetin complexes against Streptococcus pneumoniae.
Osman ME; Abo-Elnasr AA; Mohamed ET
Sci Rep; 2024 Jun; 14(1):12876. PubMed ID: 38834612
[TBL] [Abstract][Full Text] [Related]
3. Combination of Cefditoren and
Llamosí M; Sempere J; Coronel P; Gimeno M; Yuste J; Domenech M
Microbiol Spectr; 2022 Dec; 10(6):e0341522. PubMed ID: 36445126
[TBL] [Abstract][Full Text] [Related]
4. Evolving clinical problems with Streptococcus pneumoniae: increasing resistance to antimicrobial agents, and failure of traditional optochin identification in Chicago, Illinois, between 1993 and 1996.
Borek AP; Dressel DC; Hussong J; Peterson LR
Diagn Microbiol Infect Dis; 1997 Dec; 29(4):209-14. PubMed ID: 9458976
[TBL] [Abstract][Full Text] [Related]
5. Quercetin, a pneumolysin inhibitor, protects mice against Streptococcus pneumoniae infection.
Lv Q; Zhang P; Quan P; Cui M; Liu T; Yin Y; Chi G
Microb Pathog; 2020 Mar; 140():103934. PubMed ID: 31862394
[TBL] [Abstract][Full Text] [Related]
6. Amoxicillin-resistant
Dewachter L; Dénéréaz J; Liu X; de Bakker V; Costa C; Baldry M; Sirard JC; Veening JW
Elife; 2022 Jun; 11():. PubMed ID: 35748540
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and antimicrobial susceptibility of Streptococcus pneumoniae isolated from patients at Jikei University Hospitals after the implementation of the pneumococcal vaccination program in Japan.
Ando T; Masaki T; Kono M; Nagano Y; Sakamoto K; Tamura T; Abe M; Matsushima M; Nakada K; Matsuura T
J Infect Chemother; 2020 Jul; 26(7):769-774. PubMed ID: 32417263
[TBL] [Abstract][Full Text] [Related]
8. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016.
Zhao C; Li Z; Zhang F; Zhang X; Ji P; Zeng J; Hu B; Hu Z; Liao K; Sun H; Zhang R; Cao B; Zhuo C; Jia W; Mei Y; Chu Y; Xu X; Yang Q; Jin Y; Fu Q; Xu X; Li H; Wang L; Ni Y; Liang H; Wang H
BMC Infect Dis; 2017 Dec; 17(1):804. PubMed ID: 29284419
[TBL] [Abstract][Full Text] [Related]
9. Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4.
Jenkins SG; Brown SD; Farrell DJ
Ann Clin Microbiol Antimicrob; 2008 Jan; 7():1. PubMed ID: 18190701
[TBL] [Abstract][Full Text] [Related]
10. The Opp (AmiACDEF) Oligopeptide Transporter Mediates Resistance of Serotype 2 Streptococcus pneumoniae D39 to Killing by Chemokine CXCL10 and Other Antimicrobial Peptides.
Bruce KE; Rued BE; Tsui HT; Winkler ME
J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29581408
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial Activity of Zabofloxacin against Clinically Isolated Streptococcus pneumoniae.
Park HS; Oh SH; Kim HS; Choi DR; Kwak JH
Molecules; 2016 Nov; 21(11):. PubMed ID: 27869677
[TBL] [Abstract][Full Text] [Related]
13. Streptococcus pneumoniae and Haemophilus influenzae type b carriage in Chinese children aged 12-18 months in Shanghai, China: a cross-sectional study.
Hu J; Sun X; Huang Z; Wagner AL; Carlson B; Yang J; Tang S; Li Y; Boulton ML; Yuan Z
BMC Infect Dis; 2016 Apr; 16():149. PubMed ID: 27080523
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program.
Gordon KA; Biedenbach DJ; Jones RN
Diagn Microbiol Infect Dis; 2003 Aug; 46(4):285-9. PubMed ID: 12944021
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal activities of parenteral antibiotics and genotype of penicillin-binding protein in Streptococcus pneumoniae and Haemophilus influenzae isolated from children's blood.
Sakata H
J Infect Chemother; 2006 Oct; 12(5):338-42. PubMed ID: 17109098
[TBL] [Abstract][Full Text] [Related]
16. Pneumococcal infection in children: rational antibiotic choice for drug-resistant Streptococcus pneumoniae.
Chiou CC; Hseih KS
Acta Paediatr Taiwan; 2003; 44(2):67-74. PubMed ID: 12845845
[TBL] [Abstract][Full Text] [Related]
17. Infective endocarditis caused by highly penicillin-resistant Streptococcus pneumoniae: successful treatment with cefuzonam, ampicillin and imipenem.
Okumura A; Ito K; Kondo M; Takahashi H; Hayakawa F; Ogawa A; Kuno K
Pediatr Infect Dis J; 1995 Apr; 14(4):327-9. PubMed ID: 7603821
[No Abstract] [Full Text] [Related]
18. Quercetin impairs Streptococcus pneumoniae biofilm formation by inhibiting sortase A activity.
Wang J; Song M; Pan J; Shen X; Liu W; Zhang X; Li H; Deng X
J Cell Mol Med; 2018 Dec; 22(12):6228-6237. PubMed ID: 30334338
[TBL] [Abstract][Full Text] [Related]
19. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
[TBL] [Abstract][Full Text] [Related]
20. In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin.
Giron KP; Gross ME; Musher DM; Williams TW; Tharappel RA
Antimicrob Agents Chemother; 1995 Dec; 39(12):2798-800. PubMed ID: 8593023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
